Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Metagenomic analysis of bat coronaviruses from Eswatini

PROVIDER: PRJNA789782 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17257193_1.fastq.gz	Fastqsanger.gz
	SRR17257193_2.fastq.gz	Fastqsanger.gz
	SRR17257194_1.fastq.gz	Fastqsanger.gz
	SRR17257194_2.fastq.gz	Fastqsanger.gz
	SRR17257195_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Bat Coronaviruses

Project description:Indian Ocean Bat Coronaviruses

| PRJNA732935 | ENA

Project description:Bat coronaviruses from the Indochinese peninsula

| PRJNA796968 | ENA

Project description:Characterization of bat coronaviruses in Korea

| PRJNA833201 | ENA

Project description:Twenty-four bat coronaviruses identifed by metatranscriptomic sequencing

| PRJNA707649 | ENA

Genomic determinants of Furin cleavage in diverse European SARS-related bat coronaviruses

Project description:Furin cleavage in European SARS-related bat coronaviruses

| PRJEB51900 | ENA

Viral Metagenomic Analysis of Bat Viromes

Project description:Viral Metagenomic Analysis of Bat Viromes

| PRJNA1068529 | ENA

viral metagenome

Project description:Viral metagenomic analysis of bat feces

| PRJDB31 | ENA

Intestinal Flora of ADPKD and Prostate Cancer

Project description:Primary outcome(s): Metagenomic analysis and Metabolome analysis of Intestinal flora before, 2weeks, 1months, 3months, 6months, 12months

| 2636430 | ecrin-mdr-crc

Project description:The metagenomic analysis of 18 bat species from Switzerland

| PRJNA693645 | ENA

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Project description:All coronaviruses known to have recently emerged as human pathogens probably originated in bats1. Here we use a single experimental platform based on immunodeficient mice implanted with human lung tissue (hereafter, human lung-only mice (LoM)) to demonstrate the efficient in vivo replication of severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as two endogenous SARS-like bat coronaviruses that show potential for emergence as human pathogens. Virus replication in this model occurs in bona fide human lung tissue and does not require any type of adaptation of the virus or the host. Our results indicate that bats contain endogenous coronaviruses that are capable of direct transmission to humans. Our detailed analysis of in vivo infection with SARS-CoV-2 in human lung tissue from LoM showed a predominant infection of human lung epithelial cells, including type-2 pneumocytes that are present in alveoli and ciliated airway cells. Acute infection with SARS-CoV-2 was highly cytopathic and induced a robust and sustained type-I interferon and inflammatory cytokine and chemokine response. Finally, we evaluated a therapeutic and pre-exposure prophylaxis strategy for SARS-CoV-2 infection. Our results show that therapeutic and prophylactic administration of EIDD-2801?an oral broad-spectrum antiviral agent that is currently in phase II/III clinical trials?markedly inhibited SARS-CoV-2 replication in vivo, and thus has considerable potential for the prevention and treatment of COVID-19.

2020-09-23 | GSE155286 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data